These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. Gall MA; Hougaard P; Borch-Johnsen K; Parving HH BMJ; 1997 Mar; 314(7083):783-8. PubMed ID: 9080995 [TBL] [Abstract][Full Text] [Related]
3. Microalbuminuria in an adolescent cohort with insulin-dependent diabetes mellitus. Quattrin T; Waz WR; Duffy LC; Sheldon MW; Campos SP; Albini CH; Feld LG Clin Pediatr (Phila); 1995 Jan; 34(1):12-7. PubMed ID: 7720322 [TBL] [Abstract][Full Text] [Related]
4. Incipient Diabetes Mellitus and Nascent Thyroid Disease Presenting as Beard Alopecia Areata: Case Report and Treatment Review of Alopecia Areata of the Beard. Forouzan P; Cohen PR Cureus; 2020 Jul; 12(7):e9500. PubMed ID: 32766019 [TBL] [Abstract][Full Text] [Related]
5. A High Level of Intestinal Alkaline Phosphatase Is Protective Against Type 2 Diabetes Mellitus Irrespective of Obesity. Malo MS EBioMedicine; 2015 Dec; 2(12):2016-23. PubMed ID: 26844282 [TBL] [Abstract][Full Text] [Related]
7. Vitamin B status in patients with type 2 diabetes mellitus with and without incipient nephropathy. Nix WA; Zirwes R; Bangert V; Kaiser RP; Schilling M; Hostalek U; Obeid R Diabetes Res Clin Pract; 2015 Jan; 107(1):157-65. PubMed ID: 25458341 [TBL] [Abstract][Full Text] [Related]
8. The telmisartan renoprotective study from incipient nephropathy to overt nephropathy--rationale, study design, treatment plan and baseline characteristics of the incipient to overt: angiotensin II receptor blocker, telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) Study. Makino H; Haneda M; Babazono T; Moriya T; Ito S; Iwamoto Y; Kawamori R; Takeuchi M; Katayama S J Int Med Res; 2005; 33(6):677-86. PubMed ID: 16372586 [TBL] [Abstract][Full Text] [Related]
9. Acute and long-term effect of antihypertensive treatment on exercise-induced albuminuria in incipient diabetic nephropathy. Christensen CK; Mogensen CE Scand J Clin Lab Invest; 1986 Oct; 46(6):553-9. PubMed ID: 3535002 [TBL] [Abstract][Full Text] [Related]
10. The presence of allele D of angiotensin-converting enzyme polymorphism is associated with diabetic nephropathy in patients with less than 10 years duration of Type 2 diabetes. Canani LH; Costa LA; Crispim D; Gonçalves Dos Santos K; Roisenberg I; Lisbôa HR; Sarturi Tres G; Maia AL; Gross JL Diabet Med; 2005 Sep; 22(9):1167-72. PubMed ID: 16108844 [TBL] [Abstract][Full Text] [Related]
11. Evolution of incipient nephropathy in type 2 diabetes mellitus. Lemley KV; Abdullah I; Myers BD; Meyer TW; Blouch K; Smith WE; Bennett PH; Nelson RG Kidney Int; 2000 Sep; 58(3):1228-37. PubMed ID: 10972685 [TBL] [Abstract][Full Text] [Related]
12. Elevated urinary prostaglandin excretion and the effect of indomethacin on renal function in incipient diabetic nephropathy. Mathiesen ER; Hommel E; Olsen UB; Parving HH Diabet Med; 1988 Mar; 5(2):145-9. PubMed ID: 2964980 [TBL] [Abstract][Full Text] [Related]
13. Nephro- and neuroprotective effects of rosiglitazone versus glimepiride in normoalbuminuric patients with type 2 diabetes mellitus: a randomized controlled trial. Petrica L; Petrica M; Vlad A; Dragos Jianu C; Gluhovschi G; Ianculescu C; Dumitrascu V; Giju S; Gluhovschi C; Bob F; Ursoniu S; Gadalean F; Velciov S; Bozdog G; Marian R Wien Klin Wochenschr; 2009; 121(23-24):765-75. PubMed ID: 20047115 [TBL] [Abstract][Full Text] [Related]
15. Effect of long-term administration of picotamide on baseline and exercise-induced urinary albumin excretion in patients with type II diabetes mellitus and incipient nephropathy. Giustina A; Ianniello P; Bossoni S; Comini MT; Desenzani P; Gazzoli N; Romanelli G Clin Ther; 1994; 16(2):191-9. PubMed ID: 8062315 [TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus. Johansson BL; Borg K; Fernqvist-Forbes E; Kernell A; Odergren T; Wahren J Diabet Med; 2000 Mar; 17(3):181-9. PubMed ID: 10784221 [TBL] [Abstract][Full Text] [Related]
17. New sign for incipient diabetes. Leake CD Geriatrics; 1968 Oct; 23(10):92. PubMed ID: 5676501 [No Abstract] [Full Text] [Related]
18. Skin blood cell flux in insulin-dependent diabetic subjects in relation to retinopathy or incipient nephropathy. Houben AJ; Schaper NC; Slaaf DW; Tangelder GJ; Nieuwenhuijzen Kruseman AC Eur J Clin Invest; 1992 Jan; 22(1):67-72. PubMed ID: 1559544 [TBL] [Abstract][Full Text] [Related]
19. Cardiovascular and renal protection in type 2 diabetes mellitus: the role of calcium channel blockers. Nosadini R; Tonolo G J Am Soc Nephrol; 2002 Nov; 13 Suppl 3():S216-23. PubMed ID: 12466317 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: a prospective study. Hadjadj S; Belloum R; Bouhanick B; Gallois Y; Guilloteau G; Chatellier G; Alhenc-Gelas F; Marre M J Am Soc Nephrol; 2001 Mar; 12(3):541-549. PubMed ID: 11181802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]